Halozyme's market cap is currently $7.92B. The company's EPS TTM is $1.72; its P/E ratio is 14.33; Halozyme is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is $1.90. See an overview of income statement, balance sheet, and cash flow financials.
